Wedbush Securities’s Genocea Biosciences, Inc. GNCA Stock Holding History

Wedbush Securities’s Portfolio GNCA Stock Details GNCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-45,515	Closed	-$105K	–	1051
2020 Q2	$105K	Buy	+45,515	New	+$105K	0.01%	855
2020 Q1	–	Sell	-19,100	Closed	-$40K	–	1052
2019 Q4	$40K	Buy	+19,100	New	+$45.3K	﹤0.01%	971
2019 Q3	–	Sell	-11,000	Closed	-$43K	–	1056
2019 Q2	$43K	Buy	+11,000	New	+$57.4K	﹤0.01%	954
2018 Q4	–	Sell	-1,625	Closed	-$10K	–	958
2018 Q3	$10K	Buy	+1,625	New	+$8.58K	﹤0.01%	894
2017 Q4	–	Sell	-2,563	Closed	-$30K	–	924
2017 Q3	$30K	Buy	+2,563	New	+$97.3K	﹤0.01%	817
2016 Q4	–	Sell	-1,429	Closed	-$59K	–	906
2016 Q3	$59K	Buy	1,429 +63	+5%	+$2.47K	0.01%	783
2016 Q2	$45K	Buy	+1,366	New	+$50.1K	0.01%	736

Other funds holding GNCA

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wedbush Securities's GNCA Position: Q3 2020 in Review

Wedbush Securities sold out of Genocea Biosciences, Inc. (GNCA) in Q3 2020, closing a stake of 45,515 shares — an estimated $105K sold.

Wedbush Securities first reported a position in GNCA in Q2 2016 and held it in 7 quarters. The position peaked at $105K in Q2 2020. 39 funds tracked by Wall St. Rank hold GNCA as of Q3 2020.

Wedbush Securities reported no remaining Genocea Biosciences, Inc. position as of Q3 2020 after selling out during the quarter.
Wedbush Securities sold 45,515 Genocea Biosciences, Inc. shares in Q3 2020, an estimated $105K.
Wedbush Securities first reported a position in Genocea Biosciences, Inc. in Q2 2016 and held it in 7 quarters.
Wedbush Securities's Genocea Biosciences, Inc. position peaked at $105K in Q2 2020.
39 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q3 2020.

Based on Wedbush Securities's 13F filing for Q3 2020, filed 20 Oct 2020.